Diagnostics, therapy and prevention of chronic hepatitis B from the standpoint of evidence-based medicine
Abstract
In recent years the problems of diagnostics, therapy and prevention of chronic hepatitis B are of great importance due to the high prevalence of morbidity among young and middle-aged persons. The article sets forth the literature review of the randomized controlled trials performed according to diagnostic methods, nonmedicamental and medicamental therapy, and basic methods of preventing chronic hepatitis B. Special attention was given to modern methods of diagnostics (biochemical markers - ALT, AST, alkaline phosphatase, gamma-glutamine transferase, albumin, whole blood protein, prothrombin time, general blood indices) and antiviral therapy.
About the Authors
S. Kh. Lapasov
Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan
Russian Federation
Russian Federation
L. R. Khakimova
Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan
Russian Federation
Russian Federation
M. Kh. Ablakulova
Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan
Russian Federation
Russian Federation
M. Kh. Valieva
Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan
Russian Federation
Russian Federation
References
1. Абдурахманов Д.Т. Хронический гепатит В и D. - М. : ГЭОТАР-МЕД, 2010. - С. 195-243.
2. Асадов Д.А. Клиническое руководство по диагностике, лечению и профилактике хронических гепатитов у взрослых в первичном звене здравоохранения. - Ташкент, 2013. - С. 14-29.
3. Беркоу Р., Флетчер Э.Д. Руководство по медицине (диагностика и терапия). Том 1. - М. : Мир, 1997. - С. 442-449.
4. Вудли М., Уэлан А. Терапевтический справочник Вашингтонского университета. - М., 1995. - С. 274-279.
5. Денисов И.Н., Шевченко Ю.Л., Кулаков В.И., Хаитов Р.М. Клинические рекомендации для практикующих врачей, основанные на доказательной медицине. - М. : ГЭОТАР-МЕД, 2002 - С. 324-343.
6. Ивашкин В.Т. Алкогольно-вирусные заболевания печени. - М. : ГЭОТАР-МЕД, 2007 - С. 133-143.
7. Ивашкин В.Т., Ющук Н.Д. Рекомендации по диагностике и лечению взрослых больных гепатитами В и С. - М. : ГЭОТАР-МЕД, 2015 - С. 102-153.
8. Мавейков Г.П., Сорокин Н.Ф. Клиническая диагностика (справочное пособие для семейного врача). - Минск, 1999. - С. 390-391.
9. О мерах по совершенствованию борьбы с вирусными гепатитами в республике // Минздрав Республики Узбекистан. - Приказ № 5 от 5.01.2012.
10. Учайкин В.Ф., Чередниченко Т.В., Смирнов А.В. Инфекционная гепатология. - М. : ГЭОТАР-МЕД, 2014. - С. 528-543.
11. Чучалин А.Г. Терапия. - М. : ГЭОТАР-МЕД, 1998. - С. 101-105.
12. Adams V.J., Johnson A.M., Kiyary F.B. Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases (review) // Semin Liver Dis. - 2004. - Vol. 24. - P. 3-8.
13. Arnolds K.D., Benson F.N. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference // Ann Intern Med. - 2009. - Vol. 150, N 2. - P. 111-124.
14. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis // J Viral Hepat. - 2009. - Vol. 16, N 5. - P. 300-314.
15. Chevaliez S., Pawlotsky J.M. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes // Best Pract Res Clin Gastroenterol - 2008. -Vol. 22, N 6. - P. 1031-1048.
16. Cooke G.S., Main J., Thursz M.R. Treatment for hepatitis B // BMJ. - 2010. - doi: 10.1136/bmj.b5429.
17. Chawla Y.K. Herbal medicines for liver diseases // Dig Dis Sci. - 2005. - Vol. 50, N 10. - P. 1807-1812.
18. Chen W.N. EASL Clinical Practice Guidelines: Management of chronic hepatitis B European Association for the Study of the Liver // Journal of Hepatology. - 2009. - Vol. 50. - P. 227-242.
19. Flink H.J., Van Zonneveld M., Hansen B.E., De Man R.A., Schalm S.W., Janssen H.L. Treatment with Peginterferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype. //Am J Gastroenterol. - 2006. - Vol. 101. - P. 297-303.
20. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update // Hepatology. - 2009. - Vol. 49, N 4. - P. 1335-1374.
21. Gundermann K.J., Kuenker A., Kuntz E., Droździk M. Activity of essential phospholipids (EPL) from soybean in liver diseases // Pharmacol Rep. - 2011. -Vol. 63, N 3. - P. 643-659.
22. Hoofnagle J.H., Doo E., Liang T.J., Fleischer R., Lok A.S. Management of hepatitis B: summary of a clinical research workshop. //Hepatology. - 2007. - Vol. 45. - P. 1056-1075.
23. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudatcorrespondence F., Denk H., Desmet V., Korb G., MacSween R.N.M., Phillips M.J., Portmann B.G., Poulsen H., Scheuer P.J., Schmid M., Thaler H. Histological grading and staging of chronic hepatitis //J Hepatol. - 1995. - Vol. 22, N 6. - P. 696-699.
24. Jiang H., Wang J., Zhao W. Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis. // Eur J Clin Microbiol Infect Dis. - 2012. - Vol. 36, N 8. - P. 107-117.
25. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. // Hepatology. - 2009. - Vol. 50, N 3. - P. 661-663.
26. Muriel P, Rivera-Espinoza Y. Beneficial drugs for liver diseases // J Appl Toxicol. - 2008. - Vol. 28, N 2. - P. 93-103.
27. National Travel Health Network and Centre. Hepatitis B travel health information sheet for health professionals (2007) [Электронный ресурс] / Режим доступа: www.nathnac.org, свободный (03.04.2015)
28. Poorolajal J., Mahmoodi M., Haghdoost A., Majdzadeh R., Nasseri-Moghaddam S., Ghalichi L., Fotouhi A. Booster dose vaccination for preventing hepatitis B (Cochrane Review). - The Cochrane Library, John Wiley & Sons Ltd, 2010 - Issue 11. - 34 p.
29. Poynard T., Ngo Y., Munteanu M, Thabut D, Massard J, Moussalli J, Varaud A, Benhamou Y, Ratziu V. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. // Antiviral Therapy. - 2010. - Vol. 15, N 4. - P. 617-631.
30. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T., et al. Genetic variation in IL28B is associated with chronic hepatitis B and treatment failure: a genome-wide association study // Gastroenterology. - 2010. - Vol. 138. - P. 1338-1345.
31. Rumi M.G., Aghemo A., Prati G.M., D'Ambrosio R., Donato M.F., Soffredini R., Del Ninno E., Russo A., Colombo M. Randomized study of peginterferon-alpha 2a plus ribavirin vs peginterferon-alpha 2b plus ribavirin in chronic hepatitis C //Gastroenterology. - 2010. - Vol. 138, N 1. - P. 108-115.
32. Sorrell M.F., Belongia E.A., Costa J, Gareen I.F., Grem J.L., Inadomi J.M., Kern E.R., McHugh J.A., Petersen G.M., Rein M.F., Strader D.B., Trotter H.T. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B // Ann Intern Med. - 2009. - Vol. 150, N 2. - P. 104-110.
33. Shamliyan T.A., Johnson J.R., MacDonald R., Shaukat A., Yuan J.M., Kane R.L., Wilt T.J. Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection // Journal of General Internal Medicine. - 2011. - Vol. 26, N 3. - P. 326-339.
34. Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K., Sakamoto N., Nakagawa M., Korenaga M., Hino K., Hige S., Ito Y., Mita E., Tanaka E., Mochida S., Murawaki Y., Honda M., Sakai A., Hiasa Y., Nishiguchi S., Koike A., Sakaida I., Imamura M., Ito K., Yano K., Masaki N., Sugauchi F., Izumi N., Tokunaga K., Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis B // Nat Genet. - 2009. - Vol. 41, N 10. - P. 1105-1109.
35. Weinbaum C.M., Williams I., Mast E.E., Wang S.A., Finelli L., Wasley A., Neitzel S.M., Ward J.W., Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection // MMWR Recomm Rep - 2008. - Vol. 57 (RR-8). - P. 1-20.
Review
For citations:
Lapasov S.Kh., Khakimova L.R., Ablakulova M.Kh., Valieva M.Kh. Diagnostics, therapy and prevention of chronic hepatitis B from the standpoint of evidence-based medicine. Kursk Scientific and Practical Bulletin "Man and His Health". 2015;(3):41-48. (In Russ.)
Views:
519
Email this article 